Skip to main content
Loncastuximab tesirine shows long-term efficacy in relapsed or refractory DLBCL
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Loncastuximab tesirine shows long-term efficacy in relapsed or refractory DLBCL
User login
Username
Password
Reset your password
Concept
Lead
score
Non-Hodgkin Lymphoma (NHL)
1
1
Refractory
0
0.87
Monoclonal Antibody
0
0.85
B-Cell Lymphoma
0
1
Lymphoma
0
0.35
Specialty
Lead
score
Hematology-Oncology
1
1
Pharmacist
0
1
Edit Tags